ctrl K

Price Alert

Neuphoria Therapeutics In... (NEUP)

NASDAQ: NEUP · Real-Time Price · USD

8.20

0.10 (1.23%)

At close: Aug 15, 2025, 12:10 PM

Neuphoria Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	12.61M	12.1M	23.09M	21.41M
Short-Term Investments	n/a	n/a	n/a	327.31K
Long-Term Investments	n/a	n/a	n/a	119K
Other Long-Term Assets	78.03K	78.9K	81.86K	-29.59K
Receivables	126.88K	426.09K	4.67M	192.88K
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	351.00	n/a	n/a	984.28K
Total Current Assets	13.19M	13.33M	28.76M	23.24M
Property-Plant & Equipment	218.97K	333K	464.01K	654.37K
Goodwill & Intangibles	14.16M	14.82M	15.62M	16.79M
Total Long-Term Assets	14.46M	15.24M	16.17M	17.53M
Total Assets	27.65M	28.56M	44.93M	40.77M
Account Payables	2.24M	1.44M	1.07M	772.93K
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	33.12K	n/a	n/a	n/a
Other Current Liabilities	328.89K	72.56K	281.57K	279.45K
Total Current Liabilities	3.83M	2.74M	2.31M	1.77M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	5.25M	2.47M	1.86M	1.33M
Total Long-Term Liabilities	6.33M	3.81M	3.47M	3.23M
Total Liabilities	10.16M	6.55M	5.78M	5.01M
Total Debt	272.74K	353.76K	477.15K	652.04K
Common Stock	n/a	n/a	149.75M	142.9M
Retained Earnings	-177.98M	-162.48M	-119.22M	-115.74M
Comprehensive Income	-3.01M	-3.06M	8.62M	8.6M
Shareholders Equity	17.49M	22.01M	39.15M	35.76M
Total Investments	n/a	n/a	n/a	446.31K